[October 23, 2014]

Transgenomic to Hold Third Quarter Financial Results Conference Call on October 30, 2014 at 8:30AM ET

Transgenomic, Inc. (NASDAQ: TBIO), today announced that the company will hold its Third Quarter 2014 Financial Results and Business Update Conference Call on Thursday, October 30, 2014 at 8:30 AM ET.

To participate in the call, dial 866-952-1907 from the U.S. and Canada or 785-424-1826 from international locations and enter conference ID: TRANS. The call can also be accessed through a link on the Transgenomic website, http://www.videonewswire.com/event.asp?id=100807.

A replay of the call will be available for two weeks beginning approximately two hours after the call's conclusion until 11:59 PM ET November 13, 2014. To access the replay, dial 800-723-5792 (domestic) or 402-220-2664 (international).

About Transgenomic, Inc.
Transgenomic, Inc. is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic technologies, such as its revolutionary ICE COLD-PCR (News - Alert)^TM and its unique genetic tests provided through its Patient Testing business. The company also provides specialized clinical and research services to biopharmaceutical companies developing targeted therapies and sells equipment, reagents and other consumables for applications in molecular testing and cytogenetics. Transgenomic's diagnostic technologies are designed to improve medical diagnoses and patient outcomes.

[ Back To TMCnet.com's Homepage ]